Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry.

Circulation. Cardiovascular interventions·2020

Same author

Machine learning to predict venous thrombosis in acutely ill medical patients.

Research and practice in thrombosis and haemostasis·2020

Same author

Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis.

JAMA cardiology·2020

Same author

Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation.

Journal of thrombosis and thrombolysis·2020

Same author

Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy.

Journal of the American College of Cardiology·2020

Same author

The AngelMed Guardian<sup>®</sup> System in the Detection of Coronary Artery Occlusion: Current Perspectives.

Medical devices (Auckland, N.Z.)·2020

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Prehospital Thrombolysis: A Manual from Berlin

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Thrombolytics and myocardial infarction.

Vijayalakshmi Kunadian¹, C Michael Gibson

¹Cardiothoracic Division, The James Cook University Hospital, Middlesbrough, UK.

Cardiovascular Therapeutics

|November 13, 2010

Summary

This summary is machine-generated.

Coronary artery disease (CAD) management has evolved significantly. Thrombolytic agents, from streptokinase to newer tissue plasminogen activators, improve survival in acute myocardial infarction.

More Related Videos

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Related Experiment Videos

Last Updated: Jun 6, 2026

Prehospital Thrombolysis: A Manual from Berlin

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Area of Science:

Cardiology
Pharmacology

Background:

Coronary artery disease (CAD) is the leading cause of death in the US.
Myocardial infarction (MI) is primarily caused by coronary artery occlusion.

Observation:

Streptokinase, an early thrombolytic, reduced mortality in acute MI.
Development of newer tissue plasminogen activators (tPAs) like alteplase, reteplase, and tenecteplase followed.

Findings:

Thrombolytic therapy has significantly reduced cardiovascular mortality.
Primary percutaneous coronary intervention is a key management strategy.

Implications:

Modern management of acute MI involves thrombolytic agents and percutaneous coronary intervention.
These advancements have revolutionized patient outcomes and survival rates.